Harmony Biosciences Holdings, Inc. - 10-Q Filing
Harmony Biosciences reports Q3 2025 financial results including significant customer concentration and debt obligations.
Tickers: $HRMY
Harmony Biosciences reports Q3 2025 financial results including significant customer concentration and debt obligations.
Tickers: $HRMY